XPHOZAH is the first and only phosphate absorption inhibitor (PAI) approved by the U.S. Food and Drug Administration to reduce serum phosphorus in adults with chronic kidney disease on dialysis as add ...
Prescient Therapeutics Limited (ASX: PTX) shares surged following the European Medicines Agency (EMA) granting Orphan Drug Designation to PTX-100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback